Real-time enrollment status for this acute myeloid leukemia arising from previous myelodysplastic syndrome clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 11:10 PM UTC
| NCT Number | NCT03874052 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome |
| Phase | PHASE1 |
| Target Enrollment | 51 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Jennifer Saultz |
| Last Updated on CT.gov | July 6, 2026 (Jul 6, 2026) |
As of August 31, 2026: Clinical trial NCT03874052 is currently recruiting participants. This phase1 study for acute myeloid leukemia arising from previous myelodysplastic syndrome is actively seeking new participants at 3 locations across the United States. The study is sponsored by Jennifer Saultz. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03874052 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03874052 was last updated Jul 6, 2026 (July 6, 2026). HelloStudys verifies this status automatically.